{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:50:50Z","timestamp":1790985050663,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.clgc.2025.102365","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T19:17:12Z","timestamp":1745349432000},"page":"102365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Review of Relapse Detection Methods in Stage 1 Testicular Germ Cell Tumors in Patients After Orchidectomy Managed With Active Surveillance: Is Physical Examination Required?"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0364-0703","authenticated-orcid":false,"given":"A.E.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4807-8523","authenticated-orcid":false,"given":"R.","family":"Zielinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Grimison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9624-0807","authenticated-orcid":false,"given":"F.","family":"Honeyball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2025.102365_sbref0001","series-title":"Stage I Testicular Cancer Surveillance Recommendations","year":"2023"},{"key":"10.1016\/j.clgc.2025.102365_bib0002","series-title":"NCCN Clinical Practice Guidelines in Oncology: Testicular Cancer [v.2.2024]","year":"2024"},{"key":"10.1016\/j.clgc.2025.102365_bib0003","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/annonc\/mdy217","article-title":"ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up","volume":"29","author":"Honecker","year":"2018","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2025.102365_bib0004","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.eururo.2023.04.010","article-title":"European Association of Urology Guidelines on Testicular Cancer: 2023 update","volume":"84","author":"Patrikidou","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2025.102365_bib0005","first-page":"1","article-title":"Patterns of relapse in Australian patients with clinical stage 1 testicular cancer: utility of the Australian and New Zealand urogenital and prostate cancer trials group surveillance recommendations","volume":"00","author":"Conduit","year":"2023","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"10.1016\/j.clgc.2025.102365_bib0006","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2014.56.2116","article-title":"Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance","volume":"33","author":"Kollmannsberger","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102365_bib0007","first-page":"e19","article-title":"Canadian consensus guidelines for the management of testicular germ cell cancer","volume":"4","author":"Wood","year":"2010","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.clgc.2025.102365_bib0008","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/andr.280","article-title":"SWENOTECA. Surveillance vs. adjuvant therapy ofclinical stage I testicular tumors \u2013 anreview and the SWENOTECA experience","volume":"3","author":"Cohn-Cedermark","year":"2015","journal-title":"Andrology"},{"key":"10.1016\/j.clgc.2025.102365_sbref0009","series-title":"Princess Margaret Cancer Centre Clinical Practice Gudelines: Testis Cancer","author":"Catton","year":"2016"},{"key":"10.1016\/j.clgc.2025.102365_bib0010","unstructured":"Porfiri E., Stevenson, R., Patel, P., et al. Guidelines for the management of testicular cancer: West Midlands Expert Advisory Group for Urological Cancer. NHS 2024. Accessed October 7, 2024. Available from https:\/\/wmcanceralliance.nhs.uk\/images\/Documents\/Urology_including_Prostate\/Guidelines_for_Management_of_Testicular_cancer_V4_002.pdf."},{"issue":"3","key":"10.1016\/j.clgc.2025.102365_bib0011","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/bju.14967","article-title":"Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: a systematic review and meta-analysis","volume":"125","author":"Blok","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2025.102365_bib0012","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/annonc\/mdv180","article-title":"A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion","volume":"26","author":"Lago-Hernandez","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clgc.2025.102365_bib0013","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/imj.12881","article-title":"Compliance of males with stage 1 testicular germ cell tumours on an active surveillance protocol","volume":"10","author":"Honeyball","year":"2015","journal-title":"Intern Med J"},{"issue":"1-2","key":"10.1016\/j.clgc.2025.102365_bib0014","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/ans.16114","article-title":"Compliance with follow-up for patients with stage 1 testicular germ cell tumour","volume":"91","author":"Cheung","year":"2021","journal-title":"ANZ J Surg"},{"issue":"4","key":"10.1016\/j.clgc.2025.102365_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2024.102116","article-title":"Adherence outcomes and risk factors predicting nonadherence to active surveillance in patients with stage 1 testicular germ cell tumors","volume":"22","author":"Liang","year":"2024","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"10.1016\/j.clgc.2025.102365_bib0016","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/ajr.12921","article-title":"The best thing since sliced bread\u2019: patient experiences of teleoncology in western NSW","volume":"31","author":"Pye","year":"2022","journal-title":"Aust J Rural Health"},{"issue":"5","key":"10.1016\/j.clgc.2025.102365_bib0017","doi-asserted-by":"crossref","DOI":"10.1117\/1.JMI.8.5.052109","article-title":"Computed tomography recent history and future perspectives","volume":"8","author":"Hsieh","year":"2021","journal-title":"J Med Imaging"},{"issue":"1","key":"10.1016\/j.clgc.2025.102365_bib0018","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.230803","article-title":"Milestones in CT: past, present, and future","volume":"309","author":"McCollough","year":"2023","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.clgc.2025.102365_bib0019","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1148\/radiographics.14.4.7938776","article-title":"Helical CT: clinical performance and imaging strategies","volume":"14","author":"Foley","year":"1994","journal-title":"Radiographics"},{"issue":"6","key":"10.1016\/j.clgc.2025.102365_bib0020","first-page":"626","article-title":"History of contrast Media: celebrating the centenary of the use of Lipiodol\u00ae in radiology","volume":"43","author":"Bonnemain","year":"2021","journal-title":"Erciyes Med J"},{"issue":"3","key":"10.1016\/j.clgc.2025.102365_bib0021","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2967\/jnmt.107.042978","article-title":"Principles of CT and CT technology","volume":"35","author":"Goldman","year":"2007","journal-title":"J Nucl Med Technol"},{"issue":"22","key":"10.1016\/j.clgc.2025.102365_bib0022","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1200\/JCO.21.01199","article-title":"TRISST trial management group and investigators imaging modality and frequency in surveillance of stage I seminoma testicular cancer: results from a randomized, phase III, noninferiority trial (TRISST)","volume":"40","author":"Joffe","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2025.102365_bib0023","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/JU.0000000000002931","article-title":"Role of lactate dehydrogenase in identifying relapse for patients with stage I testicular cancer on surveillance","volume":"208","author":"Bobrowski","year":"2022","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102365_bib0024","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0360-3016(93)90415-R","article-title":"Results of a policy of surveillance in stage I testicular seminoma","volume":"27","author":"Warde","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clgc.2025.102365_bib0025","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.clon.2016.06.001","article-title":"Clinical characteristics and outcomes of late relapse in stage I testicular seminoma","volume":"28","author":"Hosni","year":"2016","journal-title":"Clin Oncol"},{"issue":"22","key":"10.1016\/j.clgc.2025.102365_bib0026","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1200\/JCO.18.01250","article-title":"Treatment of relapse of clinical stage I nonseminomatous germ cell tumours on surveillance","volume":"32","author":"Hamilton","year":"2019","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102365_bib0027","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1097\/JU.0000000000000862.03","article-title":"WATChmAN: A randomized trial of virtual surveillance versus standard in-person care for clinical stage I testicular cancer","volume":"203","author":"Nason","year":"2020","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102365_bib0028","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1177\/1357633X14529237","article-title":"A tele-oncology model replacing face-to-face specialist cancer care: perspectives of patients in North Queensland","volume":"20","author":"Sabesan","year":"2014","journal-title":"J Telemed Telecare"},{"issue":"14","key":"10.1016\/j.clgc.2025.102365_bib0029","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1001\/jama.2024.13964","article-title":"Telehealth vs In-person early palliative care for patients with advanced lung cancer A multisite randomized clinical trial","volume":"332","author":"Greer","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.clgc.2025.102365_bib0030","first-page":"21","article-title":"Management of testicular cancer","volume":"35","author":"Sundstrom","year":"2021","journal-title":"Scand J Urol"},{"key":"10.1016\/j.clgc.2025.102365_bib0031","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1046\/j.1464-410X.2000.00779.x","article-title":"GJS. Diagnostic delay and risk of relapse in patients with stage 1 nonseminomatous germ cell tumour followed on active surveillance","volume":"86","author":"Napier","year":"2000","journal-title":"Br J Urol"},{"issue":"4","key":"10.1016\/j.clgc.2025.102365_bib0032","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0090-4295(97)00301-4","article-title":"Active surveillance after orchiectomy for nonseminomatous testicular germ cell tumours: late relapse may occur","volume":"50","author":"Boyer","year":"1997","journal-title":"Adult Urol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102365_bib0033","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1200\/JCO.1995.13.5.1188","article-title":"Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: A single-center 10-year experience","volume":"13","author":"Gels","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2025.102365_bib0034","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1046\/j.1464-410X.2003.04270.x","article-title":"A novel surveillance protocol for stage 1 nonseminomatous germ cell testicular tumours","volume":"92","author":"Atsu","year":"2003","journal-title":"Br J Urol"},{"issue":"34","key":"10.1016\/j.clgc.2025.102365_bib0035","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1200\/JCO.2013.53.5831","article-title":"Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort","volume":"32","author":"Daugaard","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2025.102365_bib0036","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0959-8049(00)00140-4","article-title":"Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options","volume":"36","author":"Francis","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clgc.2025.102365_bib0037","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0022-5347(01)63753-4","article-title":"Clinical stage 1 testis cancer: long-term outcome of patients on surveillance","volume":"159","author":"Sogani","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2025.102365_bib0038","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.eururo.2014.07.001","article-title":"A nationwide cohort study of stage 1 Seminoma patients followed on a surveillance program","volume":"66","author":"Mortensen","year":"2014","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102365_bib0039","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1046\/j.1464-410x.1999.00869.x","article-title":"Late results of surveillance of clinical stage 1 nonseminoma germ cell testucylar tumours: 17 years' experience in a national study in New Zealand","volume":"83","author":"Colls","year":"1999","journal-title":"Br J Urol"},{"key":"10.1016\/j.clgc.2025.102365_bib0040","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/sj.bjc.6603087","article-title":"Lactate dehydrogenase is not a useful marker for relapse in patient on surveillance for stage I germ cell tumours","volume":"94","author":"Ackers","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clgc.2025.102365_bib0041","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1007\/s00432-016-2162-z","article-title":"Testicular seminoma clinical stage 1: treatment outcome on a routine care level","volume":"142","author":"Dieckmann","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2025.102365_bib0042","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4149\/BLL_2018_001","article-title":"Late relapse in stage I of nonseminomatous germ cell testicular cancer on surveillance","volume":"119","author":"Ondrusova","year":"2018","journal-title":"Bratisl Med J"},{"issue":"3","key":"10.1016\/j.clgc.2025.102365_bib0043","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.clgc.2017.12.001","article-title":"Changing practice evaluation - stage 1 seminoma: outcomes with adjuvant treatment versus surveillance: risk factors for recurrence and optimizing follow-up protocols - experience from supraregional center","volume":"16","author":"Tyrrell","year":"2017","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"10.1016\/j.clgc.2025.102365_bib0044","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/jjco\/hyy051","volume":"48","author":"Shinoda","year":"2018","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.clgc.2025.102365_bib0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12094-020-02393-9","article-title":"Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage 1 seminoma: a retrospective study of the Spanish Germ Cell Cancer Group","volume":"23","author":"Aparicio","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.clgc.2025.102365_bib0046","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1007\/s00345-014-1454-7","article-title":"Surveillance for patient with clinical stage 1 nonseminomatous testicular germ cell tumours","volume":"33","author":"Li","year":"2015","journal-title":"World J Urol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325000667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T19:53:01Z","timestamp":1752609181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325000667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S1558767325000667"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102365","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Review of Relapse Detection Methods in Stage 1 Testicular Germ Cell Tumors in Patients After Orchidectomy Managed With Active Surveillance: Is Physical Examination Required?","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102365"}}